| Line Item | 2025-12-28 | Y/Y |
|---|---|---|
| Revenue | $15.12B | -2.1% |
| Cost of Revenue | $6.33B | -2.5% |
| Gross Profit | $8.79B | -1.9% |
| R&D Expense | $382.0M | -6.4% |
| SG&A Expense | $6.09B | -3.8% |
| Operating Income | $2.41B | +31.1% |
| Interest Expense | $430.0M | -0.2% |
| Pre-tax Income | $2.00B | +41.3% |
| Income Tax | $529.0M |
| Line Item | 2025-12-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.06B | -0.7% |
| Accounts Receivable | $2.38B | +10.0% |
| Inventory | $1.67B | +4.7% |
| Current Assets | $5.70B | +3.1% |
| Total Assets | $27.08B | +5.8% |
| Current Liabilities | $5.95B | +3.6% |
| Total Liabilities | $16.31B | +2.4% |
| Line Item | 2025-12-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.20B | +24.2% |
| Capital Expenditures | $475.0M | +9.4% |
| Investing Cash Flow | -$436.0M | -2.6% |
| Financing Cash Flow | -$1.84B | -17.4% |
| Free Cash Flow | $1.72B | +29.0% |
| +37.4% |
| Net Income | $1.47B | +42.7% |
| EPS (Basic) | $0.77 | +42.6% |
| EPS (Diluted) | $0.76 | +40.7% |
| Stockholders' Equity |
| $10.77B |
| +11.3% |